NTLA
Intellia Therapeutics Inc.
$12.62
+$0.35(+2.89%)
48
Overall
60
Value
50
Tech
36
Quality
Market Cap
$1.50B
Volume
14.23M
52W Range
$5.90 - $28.25
Target Price
$33.46
Key Metrics Overview
| Market Cap | $1.50B | P/E Ratio | N/A |
| 52W High | $28.25 | 52W Low | $5.90 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 0.0% | 52W Position | 30.1% |
| Overall Score | 48 | Value Score | 60 |
| Quality Score | 36 | Technical Score | 50 |
Growth Analysis
| EPS Current Est | $-4.14 | EPS Next Est | $-4.1 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $12.62 | +2.9% | 14.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW